The FDA is defending its increased use of non-binding guidance documents rather than legally-enforceable rulemakings, arguing that guidance can better keep pace with the latest …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Greetings from
Most doctors see the advantage of using artificial intelligence (AI) in healthcare, even though they remain concerned about it, an American Medical Association (AMA) survey
The approval marks the therapy as the first and only menin inhibitor for treating patients one year and older with relapsed or refractory acute leukaemia